Cargando…

An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes

Detalles Bibliográficos
Autores principales:	Rosario, Wilfredo, D’Alessio, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876754/ https://www.ncbi.nlm.nih.gov/pubmed/26106193 http://dx.doi.org/10.2337/db15-0436

Ejemplares similares

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

GLP-2 cures the gut – What about the liver?
por: Pakarinen, Mikko P.
Publicado: (2019)

Is GLP‐1 a hormone: Whether and When?
por: D'Alessio, David
Publicado: (2016)

Health taxes for healthier lives: an opportunity for all governments
por: Ghebreyesus, Tedros Adhanom, et al.
Publicado: (2023)

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity
por: Münz, Christian, et al.
Publicado: (2005)

Healthier schools during the COVID-19 pandemic: ventilation, testing and vaccination
por: Asanati, Kaveh, et al.
Publicado: (2021)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
por: Abdalqadir, Nyan, et al.
Publicado: (2022)

Healthy People 2030: A Call to Action to Lead America to Healthier Lives
por: Giroir, Brett P.
Publicado: (2021)

Physiological extracellular electrical signals guide and orient the polarity of gut epithelial cells
por: Pu, Jin, et al.
Publicado: (2015)

Screening for unhealthy diet and exercise habits: The electronic health record and a healthier population
por: Powell, Heidi Sara, et al.
Publicado: (2019)

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
por: Liu, Yangyang, et al.
Publicado: (2020)

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
por: Salehi, Marzieh, et al.
Publicado: (2010)

Going With the Flow: Adaptation of β-Cell Function to Glucose Fluxes After Bariatric Surgery
por: Salehi, Marzieh, et al.
Publicado: (2013)

GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata
por: Goggins, Michael
Publicado: (2012)

Is endogenous GLP-1 a major influence on the orbitofrontal cortex?
por: May, Aaron A., et al.
Publicado: (2015)

Association Among Gut Microbes, Intestinal Physiology, and Autism
por: Wu, Wei-Li
Publicado: (2017)

NHS vs Modicare: The Indian Healthcare v2.0. Are we ready to build the healthier India that we envisage?
por: Nirula, Suvansh R., et al.
Publicado: (2019)

Healthier SG: for a healthier Singapore and beyond
por: The Lancet Regional Health – Western Pacific
Publicado: (2023)

The dairy fat paradox: Whole dairy products may be healthier than we thought
por: Soltani, Sepideh, et al.
Publicado: (2017)

GLP-1 and Intestinal Diseases
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Diversity, function, and transcriptional regulation of gut innate lymphocytes
por: Rankin, Lucille, et al.
Publicado: (2013)

Ontogeny of Intestinal Epithelial Innate Immune Responses
por: Hornef, Mathias W., et al.
Publicado: (2014)

Divergent Innate and Epithelial Functions of the RNA-Binding Protein HuR in Intestinal Inflammation
por: Christodoulou-Vafeiadou, Eleni, et al.
Publicado: (2018)

Gut epithelial IL-27 confers intestinal immunity through the induction of intraepithelial lymphocytes
por: Lin, Chia-Hao, et al.
Publicado: (2021)

The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent
por: Sandoval, Darleen, et al.
Publicado: (2012)

Speculations on the activation of ROS generation in C. elegans innate immune signaling
por: van der Hoeven, Ransome, et al.
Publicado: (2012)

From mental strain to gut pain: A brain‐gut pathway transducing psychological stress to intestinal inflammation
por: Schneider, Kai Markus, et al.
Publicado: (2023)

The yin and yang of intestinal epithelial cells in controlling dendritic cell function
por: Iliev, Iliyan D., et al.
Publicado: (2007)

Healthier Factories
Publicado: (1920)

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?
por: Buse, John B., et al.
Publicado: (2018)

GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
por: Gale, Edwin A.M.
Publicado: (2012)

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
por: Østergaard, Jakob A., et al.
Publicado: (2022)

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
por: Morrow, Nadya M., et al.
Publicado: (2021)

Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance
por: Swamy, Mahima, et al.
Publicado: (2015)

Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
por: Panaro, Brandon L., et al.
Publicado: (2020)

Altered signalling thresholds in T lymphocytes cause autoimmune arthritis
por: Cope, Andrew P
Publicado: (2004)

GLP-1 receptor agonist as a modulator of innate immunity
por: Chen, Jun, et al.
Publicado: (2022)

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
por: Giugliano, Dario, et al.
Publicado: (2021)

GLP-1R Signaling and Functional Molecules in Incretin Therapy
por: Wan, Wenwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bsk27vbm3v8jleail8hg886uko